Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Friday, June 27, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
The Life Cycle of an Electric Vehicle: From Mining to Recycling
Mack Trucks Launches All-New Mack Anthem for Regional Haul
Joby Aviation Partners with Flexcompute’s Flow360 for Next-Gen Aircraft Design
IDEMIA and Infineon Technologies Form Automotive Partnership
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
Lecanemab Could
Lecanemab Could
Healthcare
Modeling Published in Neurology and Therapy Suggests That Lecanemab Could Delay Progression to Alzheimer’s Dementia by Several Years
PR Newswire
-
April 28, 2022
BioArctic AB's partner Eisai announced that an article about long-term health outcomes of the investigational anti-amyloid-beta (Aβ) protofibril antibody lecanemab (BAN2401) in people living...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
The Life Cycle of an Electric Vehicle: From Mining to Recycling
Mack Trucks Launches All-New Mack Anthem for Regional Haul
Joby Aviation Partners with Flexcompute’s Flow360 for Next-Gen Aircraft Design
Load more
